AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $9.47
- 52-wk high
- $20.46
- High
- $9.51
- 52-wk low
- $7.21
- Low
- $9.32
- Prev close
- $9.54
- Mkt cap
- $2.12B
- P/E
- 13.5x
- Volume
- 2.38M
- Fwd P/E
- 9.6x
- Beta
- 0.77
- P/S
- 4.1x
- P/B
- 5.2x
- Profit margin
- +33.0%
- Op margin
- -123.4%
- ROE
- +41.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
$0.16 expected
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $134.2M | $139.2M | $114.5M | $124.4M |
| Cost of what it sold | $58.6M | $50.3M | $33.7M | $38.1M |
| Gross profit | $75.6M | $88.8M | $80.8M | $86.3M |
| What it spent | ||||
| Research and development | $1.5M | $1.4M | $2.6M | $6.0M |
| Sales and admin | $21.8M | $23.5M | $26.7M | $26.7M |
| Other operating costs | $1.3M | $1.2M | $1.1M | $1.1M |
| Total operating expenses | $24.6M | $26.1M | $30.4M | $33.8M |
| What was left | ||||
| Operating profit | $51.0M | $62.8M | $50.3M | $52.4M |
| Interest on debt | $1.7M | $1.6M | $2.1M | $3.4M |
| Profit before tax | $47.5M | $61.6M | $57.1M | $50.2M |
| Tax | $11.1M | $12.2M | $11.8M | $12.4M |
| Net profit | $36.4M | $49.4M | $45.3M | $37.8M |
| EBITDA | $51.2M | $65.3M | $61.1M | $57.3M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
20 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
NeutralSep 4Trading Systems Reacting to (ADMA) Volatility
NeutralSep 4ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
BearishAug 26
Macro
33 macro signals shaping ADMA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results